REVIEW OF NEW INDICATIONS – JOURNAL OF CLINICAL APHERESIS PERSPECTIVE

Código QR

REVIEW OF NEW INDICATIONS – JOURNAL OF CLINICAL APHERESIS PERSPECTIVE

Guardado en:

Detalles Bibliográficos
Autor principal:	Huy Pham
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Diseases of the blood and blood-forming organs RC633-647.5
Acceso en línea:	https://doaj.org/article/367cab3868184c039a109711d0350766
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

New Perspectives of Interferon-alpha2 and Inflammation in Treating Philadelphia-negative Chronic Myeloproliferative Neoplasms
por: Hans C. Hasselbalch, et al.
Publicado: (2021)

Looking forward by looking back: Inception of a new journal
por: Mary Cushman
Publicado: (2020)

Splenic marginal zone lymphoma: a review of the clinical presentation, pathology, molecular biology, and management
por: Teixeira Mendes LS, et al.
Publicado: (2014)

AVASCULAR NECROSIS IN CHRONIC MYELOID LEUKEMIA: A REVIEW OF PATHOPHYSIOLOGY, PATIENTS’ CHARACTERISTICS, AND CLINICAL OUTCOMES
por: Abdulrahman Al-Mashdali, et al.
Publicado: (2021)

CONCOMITANT JAK2 AND BCR-ABL1 IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA CLINICAL IMPACT AND RESPONSE TO THERAPY: A SYSTEMATIC REVIEW
por: Elrazi Ali, et al.
Publicado: (2021)

Imatinib in the treatment of chronic myeloid leukemia: current perspectives on optimal dose
por: Waclaw J, et al.
Publicado: (2015)

Trends in the treatment of cutaneous T-cell lymphoma &ndash; critical evaluation and perspectives on vorinostat
por: Zhang CL, et al.
Publicado: (2012)

Peripheral T cell lymphoma: clinical utility of romidepsin
por: Sawey K, et al.
Publicado: (2012)

CLINICAL AND LABORATORY EVALUATION OF OUR PATIENTS WITH HEREDITARY SPHEROCYTOSIS
por: Senanur Şanlı Çelik, et al.
Publicado: (2021)

THE CLINICAL PICTURE AND LABORATORY WORK-UP OF GLANZMANN THROMBASTHENIA
por: Joanna Zdziarska, et al.
Publicado: (2021)

NEW ADVANCES IN PEDIATRIC ACUTE MYELOID LEUKEMIA
por: Özlem Tüfekçi
Publicado: (2021)

Spotlight on ponatinib in the treatment of chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia: patient selection and perspectives [Erratum]
por: Anagnostou T, et al.
Publicado: (2018)

Clinical potential of carfilzomib in the treatment of relapsed and refractory multiple myeloma
por: Gupta VA, et al.
Publicado: (2013)

Clinical variables that increase the probability of pulmonary embolism diagnosis in symptomatic children
por: Kara E. Hennelly, et al.
Publicado: (2020)

Pharmacology and clinical potential of oblimersen sodium in the treatment of chronic lymphocytic leukemia
por: O&#39;Brien S, et al.
Publicado: (2012)

RETROSPECTIVE EVALUATION OF PATIENTS WITH LANGERHANS CELL HISTIOCYTOSIS FOLLOWED IN OUR CLINIC
por: Mehmet Can Ugur, et al.
Publicado: (2021)

CLINICAL PARAMETERS OF MULTIPLE MYELOMA PROGRESSION IN RESIDENTS OF THE GOMEL REGION OF BELARUS
por: Zhanna KOZICH, et al.
Publicado: (2021)

A new era in blood and lymphatic cancer biology and therapy
por: David Dingli
Publicado: (2011)

Small nucleolar RNA is potential as a novel player in leukemogenesis and clinical application
por: Li-Min Lin, et al.
Publicado: (2021)

DIAGNOSTIC APPLICATION AND CLINICAL SIGNIFICANCE OF FCM WELLS SCORING SYSTEM IN MYELODYSPLASTIC SYNDROMES
por: Reyhan Aliyeva, et al.
Publicado: (2021)

EVALUATION OF CLINICAL AND LABORATORY CHARACTERISTICS OF CHILDREN WITH RHABDOID TUMOR: A MULTICENTER STUDY
por: Firdevs AYDIN, et al.
Publicado: (2021)

Multiple Myeloma: EHA-ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up
por: Meletios A. Dimopoulos, et al.
Publicado: (2021)

Ultrastructural alterations of megakaryocytes in thrombocytopenia: A review of 43 cases
por: Brian Eyden, et al.
Publicado: (2021)

COVID-19 and thrombotic thrombocytopenic purpura: A review of literature
por: Balraj Singh, et al.
Publicado: (2021)

CLINICAL CHARACTERISTICS, AND SURVIVAL RATE OF ELDERLY PATIENTS WITH NON-HODGKIN'S LYMPHOMAS WITH PRIMARY INVOLVEMENT OF PERIPHERAL LYMPH NODES
por: Tomacinschii Victor, et al.
Publicado: (2021)

Activation of wild-type p53 by MDM2 inhibitors: a new strategy for lymphoma treatment
por: Pujals A, et al.
Publicado: (2015)

B1-CELLS OF INNATE IMMUNITY IN THE BONE MARROW IN BREAST CANCER PATIENTS: IDENTIFICATION AND THEIR RELATIONSHIP WITH CLINICAL AND MORPHOLOGICAL PARAMETERS
por: Svetlana Chulkova, et al.
Publicado: (2021)

EXTRAMEDULLARY HEMATOPOIESIS IN PATIENTS WITH TRANSFUSION DEPENDENT β-THALASSEMIA (TDT): A SYSTEMATIC REVIEW
por: Eihab Subahi, et al.
Publicado: (2021)

Clinical relevance of hepatitis B core total antibody in the detection of occult hepatitis B infection in patients with liver disease and blood donors
por: Vijeta Bajpai, et al.
Publicado: (2021)

EPIDEMIOLOGY, TREATMENT PATTERNS, AND CLINICAL OUTCOMES AMONG PATIENTS WITH ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA (ATTP) IN THE UNITED STATES: AN ELECTRONIC HEALTH RECORDS ANALYSIS
por: Ayoade Adeyemi, et al.
Publicado: (2021)

LATE DIAGNOSIS OF CONGENITAL METHEMOGLOBINEMIA IN A 33-YEAR-OLD CYANOTIC PATIENT, CASE REPORT AND REVIEW OF LITERATURE
por: MAYA ALDEEB, et al.
Publicado: (2021)

Leptomeningeal myelomatosis in previously treated high-risk kappa light chain multiple myeloma: case report and literature review
por: Ohanian M, et al.
Publicado: (2011)

DIRECT ORAL ANTICOAGULANTS IN SICKLE CELL DISEASE, WHERE WE STAND AND WHERE WE ARE HEADING: A SYSTEMATIC REVIEW
por: Waail Rozi, et al.
Publicado: (2021)

The European Medicines Agency Review of Tafasitamab in Combination With Lenalidomide for the Treatment of Adult Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
por: Julio Delgado, et al.
Publicado: (2021)

The absolute lymphocyte/monocyte ratio recovery during ABVD treatment cycles is not significantly impacted by the use of myeloid growth factors and predicts clinical outcomes in classical Hodgkin lymphoma regardless of their use
por: Kaufman GP, et al.
Publicado: (2014)

MicroRNA dysregulation in B-cell non-Hodgkin lymphoma
por: Lim EL, et al.
Publicado: (2013)

Critical appraisal of belinostat in the management of T-cell lymphoma – patient considerations
por: Bodiford A, et al.
Publicado: (2015)

The expanding role of bendamustine in chronic lymphocytic leukemia
por: Nair KS, et al.
Publicado: (2015)

Bortezomib in autoimmune hemolytic anemia and beyond
por: Raffaella Pasquale, et al.
Publicado: (2021)

Life-Threatening Retroperitoneal Hematoma in a Patient with COVID-19
por: Monarch Shah, et al.
Publicado: (2021)